Use of recombinant interferon in HSV-1 recurrence in the rabbit.
The use of recombinant human interferon alpha subtype D (RIFN alpha D) was effective in reducing shedding of herpes simplex virus type-1 induced by iontophoresis of 6-hydroxydopamine and epinephrine. A post stimulation treatment schedule of RIFN alpha D, one drop four times a day was as effective as pretreatment, using the same dose regimen. The levels of interferon (IFN) present in the assay system are not sufficient to produce an antiviral effect. The levels of IFN required to suppress cell growth are substantially higher than the concentrations detected in the assay system.
D000818:Animals; D002452:Cell Count; D002460:Cell Line; D003315:Cornea / Q000473:pathology; D007372:Interferons / Q000378:metabolism / Q000627:therapeutic use*; D007635:Keratitis, Dendritic / Q000188:drug therapy* / Q000382:microbiology; D008297:Male; D011817:Rabbits; D011994:Recombinant Proteins / Q000378:metabolism / Q000627:therapeutic use*; D012008:Recurrence; D018139:Simplexvirus / Q000302:isolation & purification; D013666:Tears / Q000378:metabolism / Q000382:microbiology
D011994:Recombinant Proteins; D007372:Interferons